Browse Pet Safety Reports
143,870 FDA adverse event reports for pets.
FDA Veterinary Adverse Event Database
Browse 143,870 adverse event reports collected by the FDA's Center for Veterinary Medicine. Each report includes the animal species, breed, drug or product involved, observed reactions, and outcome. Reports flagged as "serious" involve death, life-threatening conditions, or hospitalization. Use the filters to narrow results by species, outcome severity, or keyword. Note that a higher number of reports does not necessarily indicate a less safe product, widely prescribed drugs naturally accumulate more reports.
Pet Adverse Event Reports
Browse 143,870 FDA veterinary adverse event reports for Cat.
| Date | Species | Breed | Drug | Reaction | Outcome |
|---|---|---|---|---|---|
| Apr 12, 2025 | Cat | Domestic Shorthair | Velagliflozin Proline Monohydrate | Loose stool; Discomfort NOS | Outcome Unknown |
| Apr 12, 2025 | Cat | Cat (unknown) | Fluralaner Spot-On Solution | Lack of efficacy (ectoparasite) - flea | Ongoing |
| Apr 12, 2025 | Cat | Cat (unknown) | Fluralaner Spot-On Solution | Lack of efficacy (ectoparasite) - flea | Ongoing |
| Apr 12, 2025 | Cat | Domestic Shorthair | Maropitant Citrate | Elevated creatinine; Low creatinine; Lethargy (see also Central nervous syste... | Euthanized |
| Apr 12, 2025 | Cat | Domestic Shorthair | Velagliflozin Proline Monohydrate | Lack of efficacy - NOS | Outcome Unknown |
| Apr 12, 2025 | Cat | Domestic Shorthair | Bexagliflozin | Weakness; Diabetic ketoacidosis; Hypercalcaemia | Ongoing |
| Apr 12, 2025 | Cat | Maine Coon | Selamectin | Application site hair loss; Application site reddening | Ongoing |
| Apr 12, 2025 | Cat | Domestic Shorthair | Velagliflozin Proline Monohydrate | Elevated creatinine; Low creatinine; Lethargy (see also Central nervous syste... | Euthanized |
| Apr 12, 2025 | Cat | Domestic Shorthair | Bexagliflozin | Vomiting; Diarrhoea | Recovered/Normal |
| Apr 12, 2025 | Cat | Domestic Shorthair | Selamectin | Application site scratching; Excessive chewing, licking and/or grooming; Appl... | Ongoing |
| Apr 12, 2025 | Cat | Domestic Shorthair | Selamectin;Sarolaner | Vomiting bile; Hiding; Not eating; Not drinking | Outcome Unknown |
| Apr 12, 2025 | Cat | Domestic Shorthair | Frunevetmab | Seizure NOS | Ongoing |
| Apr 12, 2025 | Cat | Domestic Shorthair | Fluralaner Spot-On Solution | Itchy skin; Application site hair loss | Ongoing |
| Apr 12, 2025 | Cat | Domestic Shorthair | Fluralaner Spot-On Solution | Application site greasy fur; Application site lesion; Application site hair l... | Ongoing |
| Apr 12, 2025 | Cat | Domestic Longhair | Bexagliflozin | Lipaemia; Ketosis; Hypoglycaemia; Hyperproteinaemia; Hyperalbuminaemia | Recovered/Normal |
| Apr 12, 2025 | Cat | Domestic Shorthair | Eprinomectin; Praziquantel; Esafoxolaner | Application site hair loss; Application site reddening | Outcome Unknown |
| Apr 12, 2025 | Cat | Domestic Shorthair | Frunevetmab | Loose stool; Discomfort NOS | Outcome Unknown |
| Apr 12, 2025 | Cat | Domestic Shorthair | Eprinomectin; Praziquantel; Esafoxolaner | Application site hair loss; Wound; Application site scab | Outcome Unknown |
| Apr 12, 2025 | Cat | Domestic Shorthair | Velagliflozin Proline Monohydrate | Inappropriate urination; Lack of efficacy - NOS | Outcome Unknown |
| Apr 12, 2025 | Cat | Domestic Shorthair | Selamectin;Sarolaner | Application site irritation; Application site hair loss | Ongoing |
| Apr 11, 2025 | Cat | Domestic Shorthair | Eprinomectin; Praziquantel; Esafoxolaner | Head shake - behavioural disorder; Scratching; Tremor; Ataxia; Dyspnoea; Head... | Outcome Unknown |
| Apr 11, 2025 | Cat | Domestic Shorthair | Frunevetmab | Vomiting; Vocalisation; Lack of efficacy - NOS; Inappropriate defecation; Ele... | Ongoing |
| Apr 11, 2025 | Cat | Maine Coon | Velagliflozin Proline Monohydrate | Ketosis; Lethargy (see also Central nervous system depression in Neurological... | Outcome Unknown |
| Apr 11, 2025 | Cat | Domestic Shorthair | Fluralaner Spot-On Solution | Lack of efficacy (ectoparasite) - flea | Ongoing |
| Apr 11, 2025 | Cat | Domestic Shorthair | Imidacloprid; Moxidectin | Head tremor; Ataxia; Lethargy (see also Central nervous system depression in ... | Recovered/Normal |
| Apr 11, 2025 | Cat | Domestic Shorthair | Fluralaner Spot-On Solution | Lack of efficacy (ectoparasite) - flea | Ongoing |
| Apr 11, 2025 | Cat | Domestic Longhair | Fluralaner Spot-On Solution | Application site hair loss; Emesis (multiple) | Ongoing |
| Apr 11, 2025 | Cat | Cat (unknown) | Praziquantel; Emodepside | Vomiting; Not eating; Behavioural disorder NOS; Not drinking | Ongoing |
| Apr 11, 2025 | Cat | Domestic Shorthair | Velagliflozin Proline Monohydrate | Lateral recumbency; Glucosuria | Recovered/Normal |
| Apr 11, 2025 | Cat | Domestic Shorthair | Lotilaner | Lack of efficacy (ectoparasite) - flea; Tablets, Abnormal | Outcome Unknown |
| Apr 11, 2025 | Cat | Domestic Shorthair | Bexagliflozin | Increased drinking; Frequent urination; Hyperalbuminaemia; Elevated creatine-... | Outcome Unknown |
| Apr 11, 2025 | Cat | Cat (unknown) | Mirtazapine | Agitation; Lip licking; Administration error NOS | Recovered/Normal |
| Apr 11, 2025 | Cat | Domestic Shorthair | Molidustat Sodium | Lack of efficacy - NOS; Other abnormal test result NOS | Outcome Unknown |
| Apr 11, 2025 | Cat | Domestic Shorthair | Bexagliflozin | Polydipsia; Anorexia; Diabetic ketoacidosis; Weight loss | Outcome Unknown |
| Apr 11, 2025 | Cat | Domestic Shorthair | Buprenorphine | Application site alopecia | Outcome Unknown |
| Apr 11, 2025 | Cat | Domestic Shorthair | Selamectin;Sarolaner | Pinnal erythema; Alopecia local | Ongoing |
| Apr 11, 2025 | Cat | Domestic Shorthair | Velagliflozin Proline Monohydrate | Diarrhoea | Outcome Unknown |
| Apr 11, 2025 | Cat | Domestic Shorthair | Eprinomectin; Praziquantel; Esafoxolaner | Vomiting; Hiding; Lethargy (see also Central nervous system depression in Neu... | Ongoing |
| Apr 11, 2025 | Cat | Domestic Shorthair | Pradofloxacin | Ketosis; Elevated haemoglobin; Acid-base disorder; Hyperalbuminaemia; Elevate... | Outcome Unknown |
| Apr 11, 2025 | Cat | Domestic Shorthair | Velagliflozin Proline Monohydrate | Lack of efficacy - NOS | Outcome Unknown |
| Apr 11, 2025 | Cat | Cat (unknown) | Velagliflozin Proline Monohydrate | Weight loss; Ketosis | Outcome Unknown |
| Apr 11, 2025 | Cat | Siamese | Fluralaner/Moxidectin Spot-On | Lack of efficacy (ectoparasite) - flea | Ongoing |
| Apr 11, 2025 | Cat | Domestic Shorthair | Eprinomectin; Praziquantel; Esafoxolaner | Vomiting; Lethargy (see also Central nervous system depression in Neurologica... | Outcome Unknown |
| Apr 11, 2025 | Cat | Domestic Shorthair | Velagliflozin Proline Monohydrate | Ketosis; Elevated haemoglobin; Acid-base disorder; Hyperalbuminaemia; Elevate... | Outcome Unknown |
| Apr 11, 2025 | Cat | Domestic Shorthair | Velagliflozin Proline Monohydrate | Elevated alanine aminotransferase (ALT); Elevated blood urea nitrogen (BUN); ... | Ongoing |
| Apr 11, 2025 | Cat | Domestic Longhair | Eprinomectin; Praziquantel; Esafoxolaner | Application site alopecia; Application site erythema | Recovered/Normal |
| Apr 11, 2025 | Cat | Cat (unknown) | Velagliflozin Proline Monohydrate | Dermatitis; Weight loss; Constipation; Lack of efficacy - NOS | Outcome Unknown |
| Apr 11, 2025 | Cat | Crossbred Feline/cat, Domes... | Fluralaner/Moxidectin Spot-On | Lack of efficacy (ectoparasite) - flea | Ongoing |
| Apr 11, 2025 | Cat | Cat (unknown) | Fluralaner/Moxidectin Spot-On | Lethargy (see also Central nervous system depression in Neurological) | Recovered/Normal |
| Apr 11, 2025 | Cat | Domestic Shorthair | Fluralaner Spot-On Solution | Application site hair loss | Ongoing |
Frequently Asked Questions
Contact your veterinarian immediately. If the reaction is severe, difficulty breathing, seizures, collapse, or severe swelling, seek emergency veterinary care right away. After your pet is stabilized, report the adverse event to the FDA through safetyreporting.hhs.gov or by calling 1-888-FDA-VETS (1-888-332-8387). Reporting helps the FDA identify safety issues that can lead to label changes or product recalls.
Dogs account for the majority of adverse event reports, followed by cats. This reflects both the larger pet population and wider range of medications for these species. Flea and tick products, pain medications (NSAIDs), and heartworm preventives are among the product categories with the highest report counts across all species.
Not necessarily. A drug used by millions of pets will have more reports in absolute numbers than a niche product, even if the actual rate of adverse events is lower. The FDA uses these reports as one of many tools to evaluate drug safety, looking for patterns and statistical signals rather than raw counts alone. Always consult your veterinarian before changing any medication.